A rare occurrence and near miss! Should a TTR gene test be routinely performed for suspected ATTR-cardiomyopathy?

"A rare occurrence and near miss! Should a TTR gene test be routinely performed for suspected ATTR-cardiomyopathy?." Amyloid, ahead-of-print(ahead-of-print), pp. 1–2 Disclosure statementBharadwaj Satyavolu: none. Genise Green: none. Anthony Jake Demetris: none. Prem Soman: Grants to the University of Pittsburgh: Astellas, Pfizer; Personal Fees: Alnylam, Pfizer, Eidos, Spectrum Dynamics.Additional informationFundingThe author(s) reported there is no funding associated with the work featured in this article.